/CVRX

CVRx Inc

CVRX

$2.88USD↑+0.70%+0.02 today

MARKET CAP

76.7M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$2

$11

AI Summary

Stalk

StalkMedium

Yesterday’s bearish medium-term stance was invalidated by late-June’s F candle and Bullish Pivot Point closing above the 9/21 EMAs, signaling structural repair. CVRX now sits in an early Stage 1 consolidation below the 50 DMA with medium-term bias turned Bullish. Short-term timing is Neutral; execution should be deferred by stalking pullbacks into the 9/21 EMA support or lower consolidation boundary. A decisive close below the 9/21 EMA region would invalidate this bullish posture.

↑Devoted Health’s coverage decision increases institutional reimbursement and patient access for Barostim.
↑Q2 2026 revenue rose 16% YoY to $15.7 M; net loss narrowed to $14 M (–$0.53/sh), showing cost control.
↓Full-year revenue guidance cut from $63–67 M to $58–60 M; shares slid 60% on the revision.

Full analysis →

Buying

7

institutions

Selling

1

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.25 M	6.40 M	+218.90 K	-34.1%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	230.00 K	1.18 M	+210.70 K	+547.5%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	105.61 K	542.86 K	+15.71 K	-36.2%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	90.41 K	464.72 K	+29.29 K	-19.6%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	26.77 K	137.61 K	+26.77 K	+0.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	18.51 K	109.93 K	+11.77 K	+84.1%	0.00%
MM Millennium Management LLC Q2 2026	BUY	16.43 K	84.48 K	+2.77 K	-34.6%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-630.81 K	-100.0%	0.00%